Related Experiment Videos

Electrical status epilepticus in childhood: treatment with short cycles of high dosage benzodiazepine (preliminary

M De Negri1, M G Baglietto, R Biancheri

  • 1Department of Child Neuropsychiatry, G. Gaslini Institute, Genoa University, Italy.

Brain & Development
|July 1, 1993
PubMed

Insights

High-dose benzodiazepines (BZ) show promise for treating electrical status epilepticus in children. This short-cycle BZ therapy proved effective in 87% of patients who responded to a diazepam (DZP) test.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Pharmacology

Background:

  • Electrical status epilepticus during childhood (ESES) is a rare but serious condition.
  • Current treatment options for ESES can be limited, with varying efficacy.
  • Identifying responsive patients early is crucial for effective management.

Purpose of the Study:

  • To evaluate the efficacy of a novel, short-cycle, high-dose benzodiazepine (BZ) treatment for ESES.
  • To determine if patient response to a diazepam (DZP) bolus test predicts treatment success.

Main Methods:

  • A prospective study involving pediatric patients diagnosed with ESES.
  • Administration of relatively high doses of BZs in short, 3-week treatment cycles.
  • Inclusion of patients who demonstrated responsiveness during a diazepam (DZP) bolus test.

Main Results:

  • The proposed BZ treatment regimen yielded positive results in 7 out of 8 patients (87%) who were responsive to the DZP test.
  • A significant positive outcome was observed in a majority of the targeted patient group.

Conclusions:

  • Short-cycle, high-dose benzodiazepine therapy is an effective treatment for ESES in children who are responsive to diazepam.
  • The diazepam bolus test serves as a reliable indicator for selecting patients who will benefit from this BZ treatment approach.
  • This therapeutic strategy offers a promising option for managing ESES in pediatric populations.

Related Concept Videos